[시장보고서]프리필드 시린지 시장 규모, 점유율, 동향 분석 보고서 : 재료별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

프리필드 시린지 시장 규모, 점유율, 동향 분석 보고서 : 재료별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Prefilled Syringes Market Size, Share & Trends Analysis Report By (Disposable, Reusable), By Material (Glass, Plastic), By Application (Anaphylaxis, Diabetes), End Use, By Region, And Segment Forecasts, 2025 - 2030

상품코드 : 1654433

리서치사 : Grand View Research

발행일 : 2025년 01월

페이지 정보 : 영문 160 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,575,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,017,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,899,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

프리필드 시린지 시장의 성장과 동향

Grand View Research, Inc의 최신 보고서에 따르면 세계의 프리필드 시린지 시장 규모는 2030년까지 167억 3,000만 달러에 달할 것으로 예상되며, 2025-2030년 연평균 13.50%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예상됩니다.

시장 확대의 주요 요인으로는 자동 주사기의 기술 발전과 1회 투여당 가격 하락으로 인한 프리필드 시린지 사용 확대 등을 꼽을 수 있습니다.

현재 COVID-19 팬데믹은 산업계에 큰 영향을 미칠 것으로 예상됩니다. 2021년 12월 American Pharmaceutical Review에 따르면 COVID-19 백신은 전 세계 팬데믹에 대응하기 위해 전례 없는 속도로 생산되고 있으며, COVID-19 백신 접종량은 2021년 11월 9일까지 7억 3천만 회에 달했습니다. 2021년 11월 9일까지 COVID-19 백신 접종량은 73억 회에 이르렀으며, 매일 약 3,030만 회 분량이 제공되고 있습니다.

COVID-19의 결과로 COVID-19 백신 생산이 증가함에 따라 프리필드 시린지에 대한 수요가 증가하고 있습니다. 예를 들어 2022년 3월, 쇼트는 헝가리의 프리필러블 유리 주사기 생산 능력 확장을 포함하여 제약 부문에 대한 추가 투자를 발표했습니다. 생산 능력의 확대는 세계 시장에 이익을 가져다 줄 것이며, 주요 제약사 및 위탁 생산 업체들에게 더 큰 공급 안정성을 가져다 줄 것으로 보입니다. 그 결과, 2020년 코로나바이러스 감염증의 발생으로 인해 프리필드 시린지 판매는 전 세계에서 증가했습니다.

또한 심장질환과 같은 COVID-19의 가장 심각한 부작용을 치료하는 데 사용되는 응급 주사기는 역사적으로 부족했습니다. COVID-19 팬데믹으로 인한 수요 증가에도 불구하고 제조업체들은 국가 의약품 부족 리스트에 추가되었거나 추가될 가능성이 있는 의약품에 대해 고품질의 보호된 공급 기지를 식별하는 다양한 프로그램을 제공합니다. 예를 들어 2019년 10월 Premier Inc.는 Amphastar Pharmaceuticals, Inc.와 제휴하여 ProvideGx 프로그램을 통해 피토나디온 주사제 및 황산염, 포도당, 탄산나트륨, 에피네프린, 아트로핀, 염화칼슘, 리도카인, 아트로핀, 염화칼슘, 리도카인의 응급용 리도카인의 응급용, 프리필드 시린지를 의료진에게 제공했습니다. 이러한 특성은 유리한 시장 성장 전망을 창출할 것으로 예상됩니다.

프리필드 시린지 시장 보고서 하이라이트

일회용 부문은 2024년 91.5%의 가장 큰 시장 점유율을 차지하며 예측 기간 중 가장 빠른 CAGR을 나타낼 것으로 예상됩니다.
유리 부문은 2024년 50.4%로 가장 큰 점유율을 차지했습니다. 유리는 습기, 산소, 빛과 같은 외부 요소에 대한 강력한 장벽 역할을 합니다.
백신 및 예방접종 부문은 2024년 25.9%의 최대 점유율을 차지했습니다. 많은 백신은 일정 기간 중 여러 번 접종해야 합니다.
북미 프리필드 시린지 시장은 2024년 32.0%의 매출 점유율을 차지했습니다.

지역 대시보드
지역별 프리필드 시린지 시장 변수 분석
프리필드 시린지 시장 : 유형, 재료 용도, 유통 채널에 의한 지역 추정·동향 분석
2018-2030년 시장 규모와 예측과 동향 분석
북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제9장 경쟁 구도

시장 참여 기업의 분류
주요 기업 개요
- BD
- Gerresheimer AG
- SCHOTT Pharma AG
- Stevanato Group
- Nipro Corporation
- Terumo Corporation
- West pharmaceuticals
- Fresenius
- Catalent
- Aptar Pharma

KSA

영문 목차

영문목차

Prefilled Syringes Market Growth & Trends:

The global prefilled syringes market size is anticipated to reach USD 16.73 billion by 2030, expanding at a CAGR of 13.50% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key factors driving the market expansion include technological advancements in auto-injectors and growing usage of prefilled syringes owing to its reduced prices per dose.

The current COVID-19 outbreak is expected to have a substantial impact on the industry. The pandemic has resulted in a significant surge in demand for emergency supplies, medical disposables, medicines, and hospital equipment. According to American Pharmaceutical Review in December 2021, COVID-19 vaccines are being created at an unprecedented rate in response to the worldwide pandemic. COVID-19 vaccination doses totaled 7.3 billion by November 9, 2021, with approximately 30.3 million doses provided daily.

As a result of COVID-19, there has been an increase in the production of COVID-19 vaccines, resulting in increased demand for prefilled syringes. For instance, in March 2022, Schott announced further investments in its pharma sector, including expanding its capacity in Hungary for prefillable glass syringe production. The increased capacity is likely to benefit the global market and provide greater supply security for major pharmaceutical corporations and contract manufacturing firms. As a result, due to the outbreak of coronavirus infection in 2020, sales of prefilled syringes increased globally.

Furthermore, emergency syringes used to treat some of COVID-19's most significant side effects such as heart damage have historically been scarce. Despite the heightened demand during the outbreak, manufacturers provide various programs that identifies high-quality, protected supply bases for medications that are or could be added to the national drug scarcity list. For instance, in October 2019, Premier Inc. teamed up with Amphastar Pharmaceuticals, Inc. to provide phytonadione injection and emergency, pre-filled syringes of sulphate, dextrose, sodium bicarbonate, epinephrine, atropine, calcium chloride, and lidocaine to healthcare practitioners through its ProvideGx programme. These characteristics are projected to generate lucrative market growth prospects.

Prefilled Syringes Market Report Highlights:

The disposable segment accounted for the largest market share of 91.5% in 2024 and is expected to register the fastest CAGR over the forecast period.
The glass segment accounted for the largest share of 50.4% in 2024. The glass acts as a strong barrier against external elements like moisture, oxygen, and light.
The vaccines and immunizations segment accounted for the largest share of 25.9% in 2024. Numerous vaccines require multiple doses to be administered over a period of time.
North America prefilled syringes market accounted for the 32.0% revenue share in 2024

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.1. Segment Definitions
- 1.1.1. Type
- 1.1.2. Material
- 1.1.3. Application
- 1.1.4. Distribution Channel
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecasts timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
  - 1.3.5.1. Data for primary interviews in North America
  - 1.3.5.2. Data for primary interviews in Europe
  - 1.3.5.3. Data for primary interviews in Asia Pacific
  - 1.3.5.4. Data for primary interviews in Latin America
  - 1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Material outlook
- 2.2.3. Application outlook
- 2.2.4. Distribution channel outlook
2.3. Regional outlook
2.4. Competitive Insights

Chapter 3. Prefilled Syringes Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Steep rise in the development of biological therapies
  - 3.2.1.2. High demand for the improved safety in injectable
  - 3.2.1.3. Growing adoption of self-care devices
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Limited production of plastic syringes
  - 3.2.2.2. Negative impact on the environment due to pollution
3.3. Prefilled Syringes Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Economic landscape
  - 3.3.2.3. Social landscape
  - 3.3.2.4. Technological landscape
  - 3.3.2.5. Environmental landscape
  - 3.3.2.6. Legal landscape

Chapter 4. Prefilled Syringes Market: Material Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Prefilled Syringes Market: Material Movement Analysis
4.3. Prefilled Syringes Market by Material Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Glass
- 4.5.1. Glass Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Plastic
- 4.6.1. Plastic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Prefilled Syringes Market: Type Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Prefilled Syringes Market: Type Movement Analysis
5.3. Prefilled Syringes Market by Type Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Disposable
- 5.5.1. Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Reusable
- 5.6.1. Reusable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Prefilled Syringes Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Prefilled Syringes Market: Application Movement Analysis
6.3. Prefilled Syringes Market by Application Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Vaccines and immunizations
- 6.5.1. Vaccines and Immunizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Rheumatoid Arthritis
- 6.6.1. Rheumatoid Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Anaphylaxis
- 6.7.1. Anaphylaxis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Diabetes
- 6.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Autoimmune diseases
- 6.9.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Oncology
- 6.10.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.11. Others
- 6.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Prefilled Syringes Market: Distribution Channel Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Prefilled Syringes Market: Distribution Channel Movement Analysis
7.3. Prefilled Syringes Market by Distribution Channel Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. Hospitals
- 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Mail Order Pharmacies
- 7.6.1. Mail Order Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Ambulatory Surgery Centers
- 7.7.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Prefilled Syringes Market: Regional Estimates & Trend Analysis

8.1. Regional Dashboard
8.2. Regional Prefilled Syringes Market movement analysis
8.3. Prefilled Syringes Market: Regional Estimates & Trend Analysis by Type, Material Application & Distribution Channel
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5. North America
- 8.5.1. North America Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. U.S.
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Competitive Scenario
  - 8.5.2.3. Regulatory Framework
  - 8.5.2.4. Reimbursement scenario
  - 8.5.2.5. U.S. Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Canada
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Competitive Scenario
  - 8.5.3.3. Regulatory Framework
  - 8.5.3.4. Reimbursement scenario
  - 8.5.3.5. Canada Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. Mexico
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Competitive Scenario
  - 8.5.4.3. Regulatory Framework
  - 8.5.4.4. Reimbursement scenario
  - 8.5.4.5. Mexico Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. Europe
- 8.5.6. Europe Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. UK
  - 8.5.7.1. Key Country Dynamics
  - 8.5.7.2. Competitive Scenario
  - 8.5.7.3. Regulatory Framework
  - 8.5.7.4. Reimbursement scenario
  - 8.5.7.5. UK Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.8. Germany
  - 8.5.8.1. Key Country Dynamics
  - 8.5.8.2. Competitive Scenario
  - 8.5.8.3. Regulatory Framework
  - 8.5.8.4. Reimbursement scenario
  - 8.5.8.5. Germany Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.9. France
  - 8.5.9.1. Key Country Dynamics
  - 8.5.9.2. Competitive Scenario
  - 8.5.9.3. Regulatory Framework
  - 8.5.9.4. Reimbursement scenario
  - 8.5.9.5. France Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.10. Italy
  - 8.5.10.1. Key Country Dynamics
  - 8.5.10.2. Competitive Scenario
  - 8.5.10.3. Regulatory Framework
  - 8.5.10.4. Reimbursement scenario
  - 8.5.10.5. Italy Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.11. Spain
  - 8.5.11.1. Key Country Dynamics
  - 8.5.11.2. Competitive Scenario
  - 8.5.11.3. Regulatory Framework
  - 8.5.11.4. Reimbursement scenario
  - 8.5.11.5. Spain Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.12. Denmark
  - 8.5.12.1. Key Country Dynamics
  - 8.5.12.2. Competitive Scenario
  - 8.5.12.3. Regulatory Framework
  - 8.5.12.4. Reimbursement scenario
  - 8.5.12.5. Denmark Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.13. Sweden
  - 8.5.13.1. Key Country Dynamics
  - 8.5.13.2. Competitive Scenario
  - 8.5.13.3. Regulatory Framework
  - 8.5.13.4. Reimbursement scenario
  - 8.5.13.5. Sweden Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.14. Norway
  - 8.5.14.1. Key Country Dynamics
  - 8.5.14.2. Competitive Scenario
  - 8.5.14.3. Regulatory Framework
  - 8.5.14.4. Reimbursement scenario
  - 8.5.14.5. Norway Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
- 8.6.1. Asia Pacific Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Japan
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Competitive Scenario
  - 8.6.2.3. Regulatory Framework
  - 8.6.2.4. Reimbursement scenario
  - 8.6.2.5. Japan Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. China
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Competitive Scenario
  - 8.6.3.3. Regulatory Framework
  - 8.6.3.4. Reimbursement scenario
  - 8.6.3.5. China Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. India
  - 8.6.4.1. Key Country Dynamics
  - 8.6.4.2. Competitive Scenario
  - 8.6.4.3. Regulatory Framework
  - 8.6.4.4. Reimbursement scenario
  - 8.6.4.5. India Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. South Korea
  - 8.6.5.1. Key Country Dynamics
  - 8.6.5.2. Competitive Scenario
  - 8.6.5.3. Regulatory Framework
  - 8.6.5.4. Reimbursement scenario
  - 8.6.5.5. South Korea Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.6. Australia
  - 8.6.6.1. Key Country Dynamics
  - 8.6.6.2. Competitive Scenario
  - 8.6.6.3. Regulatory Framework
  - 8.6.6.4. Reimbursement scenario
  - 8.6.6.5. Australia Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.7. Thailand
  - 8.6.7.1. Key Country Dynamics
  - 8.6.7.2. Competitive Scenario
  - 8.6.7.3. Regulatory Framework
  - 8.6.7.4. Reimbursement scenario
  - 8.6.7.5. Thailand Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
- 8.7.1. Latin America Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.2. Brazil
  - 8.7.2.1. Key Country Dynamics
  - 8.7.2.2. Competitive Scenario
  - 8.7.2.3. Regulatory Framework
  - 8.7.2.4. Reimbursement scenario
  - 8.7.2.5. Brazil Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.3. Argentina
  - 8.7.3.1. Key Country Dynamics
  - 8.7.3.2. Competitive Scenario
  - 8.7.3.3. Regulatory Framework
  - 8.7.3.4. Reimbursement scenario
  - 8.7.3.5. Argentina Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. Middle East & Africa
- 8.8.1. Middle East & Africa Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.2. South Africa
  - 8.8.2.1. Key Country Dynamics
  - 8.8.2.2. Competitive Scenario
  - 8.8.2.3. Regulatory Framework
  - 8.8.2.4. Reimbursement scenario
  - 8.8.2.5. South Africa Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.3. Saudi Arabia
  - 8.8.3.1. Key Country Dynamics
  - 8.8.3.2. Competitive Scenario
  - 8.8.3.3. Regulatory Framework
  - 8.8.3.4. Reimbursement scenario
  - 8.8.3.5. Saudi Arabia Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.4. UAE
  - 8.8.4.1. Key Country Dynamics
  - 8.8.4.2. Competitive Scenario
  - 8.8.4.3. Regulatory Framework
  - 8.8.4.4. Reimbursement scenario
  - 8.8.4.5. UAE Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.5. Kuwait
  - 8.8.5.1. Key Country Dynamics
  - 8.8.5.2. Competitive Scenario
  - 8.8.5.3. Regulatory Framework
  - 8.8.5.4. Reimbursement scenario
  - 8.8.5.5. Kuwait Prefilled Syringes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Market Participant Categorization
9.2. Key Company Profiles
- 9.2.1. BD
  - 9.2.1.1. Company overview
  - 9.2.1.2. Financial performance
  - 9.2.1.3. Product benchmarking
  - 9.2.1.4. Strategic initiatives
- 9.2.2. Gerresheimer AG
  - 9.2.2.1. Company overview
  - 9.2.2.2. Financial performance
  - 9.2.2.3. Product benchmarking
  - 9.2.2.4. Strategic initiatives
- 9.2.3. SCHOTT Pharma AG
  - 9.2.3.1. Company overview
  - 9.2.3.2. Financial performance
  - 9.2.3.3. Product benchmarking
  - 9.2.3.4. Strategic initiatives
- 9.2.4. Stevanato Group
  - 9.2.4.1. Company overview
  - 9.2.4.2. Financial performance
  - 9.2.4.3. Product benchmarking
  - 9.2.4.4. Strategic initiatives
- 9.2.5. Nipro Corporation
  - 9.2.5.1. Company overview
  - 9.2.5.2. Financial performance
  - 9.2.5.3. Product benchmarking
  - 9.2.5.4. Strategic initiatives
- 9.2.6. Terumo Corporation
  - 9.2.6.1. Company overview
  - 9.2.6.2. Financial performance
  - 9.2.6.3. Product benchmarking
  - 9.2.6.4. Strategic initiatives
- 9.2.7. West pharmaceuticals
  - 9.2.7.1. Company overview
  - 9.2.7.2. Financial performance
  - 9.2.7.3. Product benchmarking
  - 9.2.7.4. Strategic initiatives
- 9.2.8. Fresenius
  - 9.2.8.1. Company overview
  - 9.2.8.2. Financial performance
  - 9.2.8.3. Product benchmarking
  - 9.2.8.4. Strategic initiatives
- 9.2.9. Catalent
  - 9.2.9.1. Company overview
  - 9.2.9.2. Financial performance
  - 9.2.9.3. Product benchmarking
  - 9.2.9.4. Strategic initiatives
- 9.2.10. Aptar Pharma
  - 9.2.10.1. Company overview
  - 9.2.10.2. Financial performance
  - 9.2.10.3. Product benchmarking
  - 9.2.10.4. Strategic initiatives

한글목차

프리필드 시린지 시장의 성장과 동향

프리필드 시린지 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 개요

제3장 프리필드 시린지 시장의 변수, 동향, 범위

제4장 프리필드 시린지 시장 : 재료별, 추정·동향 분석

제5장 프리필드 시린지 시장 : 유형별, 추정·동향 분석

제6장 프리필드 시린지 시장 : 용도별, 추정·동향 분석

제7장 프리필드 시린지 시장 : 유통 채널별, 추정·동향 분석

제8장 프리필드 시린지 시장 : 지역별, 추정·동향 분석